Study to Investigate DRP-104 in Adults With Advanced Solid Tumors

Stopped Company decision to closing study and discontinue further patient enrollment.

Conditions

• Advanced Solid Tumor
• Non Small Cell Lung Cancer Metastatic

Interventions

• DRUG: DRP-104
• BIOLOGICAL: atezolizumab

Sponsor

Dracen Pharmaceuticals, Inc.